[{"NetIncomeLoss_1_Q1_USD":374845000.0,"CommonStockDividendsPerShareDeclared_1_Q1_USD":0.44,"FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_0_Q1_USD":99000000.0,"CommitmentsAndContingencies_0_Q1_USD":null,"ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_1_Q1_USD":9657000.0,"UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_0_Q1_USD":436000000.0,"AccruedLiabilitiesCurrent_0_Q1_USD":1535390000.0,"OtherComprehensiveIncomeOtherNetOfTax_1_Q1_USD":0.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q1_USD":-70467000.0,"NetCashProvidedByUsedInInvestingActivities_1_Q1_USD":-65410000.0,"Depreciation_1_Q1_USD":77143000.0,"InterestIncomeExpenseNonoperatingNet_1_Q1_USD":-33614000.0,"GoodwillForeignCurrencyTranslationGainLoss_1_Q1_USD":2752000.0,"NetIncomeLossAttributableToNoncontrollingInterest_1_Q1_USD":3862000.0,"PaymentsForProceedsFromOtherInvestingActivities_1_Q1_USD":0.0,"AssetsCurrent_0_Q1_USD":34700221000.0,"IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_1_Q1_shares":2118000.0,"LongTermDebt_0_Q1_USD":3700112000.0,"RestructuringSettlementAndImpairmentProvisions_1_Q1_USD":70381000.0,"LongTermDebtCurrent_0_Q1_USD":0.0,"OtherNoncashIncomeExpense_1_Q1_USD":-28480000.0,"RestructuringCharges_1_Q1_USD":70381000.0,"SellingGeneralAndAdministrativeExpense_1_Q1_USD":735068000.0,"CostOfGoodsAndServicesSold_1_Q1_USD":51064326000.0,"TreasuryStockShares_0_Q1_shares":84422104.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q1_shares":300000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q1_USD":58216000.0,"DividendsCommonStockCash_1_Q1_USD":91103000.0,"TreasuryStockValue_0_Q1_USD":6598286000.0,"ProvisionForDoubtfulAccounts_1_Q1_USD":6452000.0,"AdditionalPaidInCapitalCommonStock_0_Q1_USD":5187669000.0,"FiniteLivedIntangibleAssetsAccumulatedAmortization_0_Q1_USD":707833000.0,"EarningsPerShareBasic_1_Q1_USD":1.83,"FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_0_Q1_USD":100500000.0,"MinorityInterest_0_Q1_USD":185674000.0,"AdjustmentForAmortization_1_Q1_USD":27140000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":206801000.0,"IncreaseDecreaseInAccruedLiabilities_1_Q1_USD":-139471000.0,"AccountsReceivableNetCurrent_0_Q1_USD":14886252000.0,"IncomeTaxExpenseBenefit_1_Q1_USD":149175000.0,"CommonStockValue_0_Q1_USD":2891000.0,"Revenues_1_Q1_USD":52516556000.0,"UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_0_Q1_USD":20000000.0,"SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit_0_Q1_USD":16700000.0,"RepaymentsOfLinesOfCredit_1_Q1_USD":0.0,"TreasuryStockValueAcquiredCostMethod_1_Q1_USD":61954000.0,"IntangibleAssetsGrossExcludingGoodwill_0_Q1_USD":2570023000.0,"EffectiveIncomeTaxRateContinuingOperations_1_Q1_pure":0.283,"NetCashProvidedByUsedInFinancingActivities_1_Q1_USD":-544471000.0,"ProceedsFromIssuanceOfDebt_1_Q1_USD":31393000.0,"DepreciationNonproduction_1_Q1_USD":73945000.0,"IncreaseDecreaseInInventories_1_Q1_USD":545459000.0,"ComprehensiveIncomeNetOfTax_1_Q1_USD":413208000.0,"IncreaseDecreaseInAccountsPayable_1_Q1_USD":1721495000.0,"AmortizationOfIntangibleAssets_1_Q1_USD":25608000.0,"InventoryLIFOReservePeriodCharge_1_Q1_USD":-25727000.0,"OtherAssetsNoncurrent_0_Q1_USD":771026000.0,"ProceedsFromLinesOfCredit_1_Q1_USD":0.0,"GainLossRelatedToLitigationSettlement_1_Q1_USD":0.0,"CommonStockSharesIssued_0_Q1_shares":289115051.0,"Assets_0_Q1_USD":45846768000.0,"EarningsPerShareDiluted_1_Q1_USD":1.81,"FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_0_Q1_USD":96700000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_0_Q1_USD":97500000.0,"Goodwill_0_Q1_USD":6709471000.0,"PaymentsRelatedToTaxWithholdingForShareBasedCompensation_1_Q1_USD":23249000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q1_USD":48317000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_1_Q1_USD":44158000.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":903053000.0,"RepaymentsOfDebt_1_Q1_USD":462643000.0,"CommonStockDividendsPerShareCashPaid_1_Q1_USD":0.44,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":204683000.0,"LiabilitiesCurrent_0_Q1_USD":35044451000.0,"CommonStockSharesOutstanding_0_Q1_shares":204692947.0,"AccountsPayableCurrent_0_Q1_USD":33449690000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q1_USD":4890918000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q1_USD":234670000.0,"ProceedsFromStockOptionsExercised_1_Q1_USD":58216000.0,"SeveranceCosts1_1_Q1_USD":0.0,"LongTermDebtNoncurrent_0_Q1_USD":3640741000.0,"IntangibleAssetsNetExcludingGoodwill_0_Q1_USD":1862190000.0,"GrossProfit_1_Q1_USD":1452230000.0,"PaymentsOfDividendsCommonStock_1_Q1_USD":91103000.0,"StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0_Q1_USD":-511548000.0,"DeferredIncomeTaxLiabilitiesNet_0_Q1_USD":703646000.0,"ProceedsFromPaymentsForOtherFinancingActivities_1_Q1_USD":-910000.0,"PropertyPlantAndEquipmentNet_0_Q1_USD":1477040000.0,"NonoperatingIncomeExpense_1_Q1_USD":14268000.0,"AssetImpairmentCharges_1_Q1_USD":0.0,"IncreaseDecreaseInAccountsReceivable_1_Q1_USD":906495000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1_Q1_USD":293172000.0,"UnrecognizedTaxBenefitsPeriodIncreaseDecrease_1_Q1_USD":2900000.0,"OtherComprehensiveIncomeLossNetOfTax_1_Q1_USD":44158000.0,"StockholdersEquityOther_1_Q1_USD":910000.0,"ShareBasedCompensation_1_Q1_USD":48317000.0,"LegalFees_1_Q1_USD":32062000.0,"DeferredIncomeTaxAssetsNet_0_Q1_USD":326820000.0,"AccruedIncomeTaxesNoncurrent_0_Q1_USD":287244000.0,"CommonStockParOrStatedValuePerShare_0_Q1_USD":0.01,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_1_Q1_USD":3121000.0,"CommonStockSharesAuthorized_0_Q1_shares":600000000.0,"OperatingIncomeLoss_1_Q1_USD":547228000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_1_Q1_USD":527882000.0,"PaymentsForRepurchaseOfCommonStock_1_Q1_USD":56175000.0,"IncreaseDecreaseInAccruedIncomeTaxesPayable_1_Q1_USD":-8091000.0,"InventoryNet_0_Q1_USD":13178958000.0,"IncomeTaxesReceivable_0_Q1_USD":317656000.0,"IncreaseDecreaseInIncomeTaxesReceivable_1_Q1_USD":-170771000.0,"DeferredIncomeTaxExpenseBenefit_1_Q1_USD":72912000.0,"LiabilitiesAndStockholdersEquity_0_Q1_USD":45846768000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_0_Q1_USD":102000000.0,"ProfitLoss_1_Q1_USD":378707000.0,"OtherLiabilitiesNoncurrent_0_Q1_USD":483291000.0,"StockholdersEquity_0_Q1_USD":-697222000.0,"PaymentsToAcquirePropertyPlantAndEquipment_1_Q1_USD":65410000.0,"LitigationReserveNoncurrent_0_Q1_USD":6198943000.0,"DebtCurrent_0_Q1_USD":59371000.0,"RetainedEarningsAccumulatedDeficit_0_Q1_USD":780971000.0,"ContractWithCustomerAssetGrossCurrent_0_Q1_USD":1191767000.0,"ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_1_Q1_USD":422865000.0,"Ticker":"ABC","CIK":"1140859","name":"AMERISOURCEBERGEN CORP","OfficialName":"AmerisourceBergen Corporation Common Stock","form":"10-Q","period":"20201231","fy":"2021.0","fp":"Q1","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"34058030313.0","Country":"United States","Sector":"Health Care","Industry":"Other Pharmaceuticals","Market":"NYSE","SP500":"SP500","filed":"20210204"}]